Gendered perspectives on women's anabolic-androgenic steroid (AAS) usage practices.

The unique challenges facing women who use AAS are largely isolation and stigma, with little evidence-based practice or education being available to them online or through peer-groups. Future work may consider piloting harm reduction strategies that may be co-designed with this group.